Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2049264 | FEBS Letters | 2008 | 9 Pages |
Abstract
Farnesoid X receptor (FXR), a member of the nuclear receptor superfamily, has been shown to be important in controlling numerous metabolic pathways; these include roles in maintaining bile acid, lipid and glucose homeostasis, in preventing intestinal bacterial infection and gallstone formation and in modulating liver regeneration and tumorigenesis. The accumulating data suggest that FXR may be a pharmaceutical target for the treatment of certain metabolic diseases.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Yanqiao Zhang, Peter A. Edwards,